Lisa C. Carson - 11 Sep 2025 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
VP, Finance and Administration
Signature
/s/ Lisa C. Carson
Issuer symbol
PHIO
Transactions as of
11 Sep 2025
Transactions value $
$0
Form type
4
Filing time
15 Sep 2025, 08:28:50 UTC
Previous filing
18 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carson Lisa Cabott VP, Finance and Administration C/O PHIO PHARMACEUTICALS CORP, 411 SWEDELAND RD., STE 23-1080, KING OF PRUSSIA /s/ Lisa C. Carson 15 Sep 2025 0002073513

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common Stock, $.0001 par value Award $0 +47K $0.00 47K 11 Sep 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant.
F2 Includes shares of common stock underlying unvested restricted stock units.